Hyperbaric oxygen therapy as additional treatment in deep sternal wound infections - a single center's experience
- PMID: 27785131
- PMCID: PMC5071585
- DOI: 10.5114/kitp.2016.62604
Hyperbaric oxygen therapy as additional treatment in deep sternal wound infections - a single center's experience
Abstract
Introduction: Deep sternal wound infection (DSWI) is one of the most serious complications after cardiac surgery procedures, observed in 5% of patients. Current standard medical therapy for DSWI includes antibiotics, surgical debridement, resuturing or negative pressure wound therapy (NPWT). Unfortunately, in some cases these methods are insufficient, and additional therapeutic options are needed.
Aim: To assess the effects and usefulness of additional hyperbaric oxygen therapy (HBO2) in patients with DSWI after cardiac surgery procedures.
Material and methods: A retrospective analysis of 10 patients after cardiac surgery who developed DSWI in the period 2010-2012 was performed. After 3 months of ineffective conventional therapy including targeted antibiotic, surgical sternal debridement and NPWT, patients were qualified for additional HBO2 therapy. A total of 20 sessions of HBO2 therapy were performed, each 92 minutes long.
Results: After 4 weeks of HBO2 treatment, 7 patients presented complete wound healing with fibrous scar formation. One patient was qualified for the another cycle of HBO2 therapy with 20 additional sessions, and complete wound healing was observed. In 2 cases, after 5 and 19 sessions, HBO2 was interrupted because of improper qualifications.
Conclusions: The HBO2 as an additional therapy in DSWI was successful in 80% of cases, and no complications were observed. However, due to the small number of published studies with a small number of patients, randomized, clinical trials are needed to assess the clinical results of HBO2 in DSWI after cardiac surgery procedures.
Wstęp: Pooperacyjne zapalenie śródpiersia (DSWI) będące najczęstszym powikłaniem kardiochirurgicznym występuje u ok. 5% pacjentów. Obecnie standardowym leczeniem DSWI jest antybiotykoterapia celowana, chirurgiczne opracowanie rany, resutura mostka oraz terapia podciśnieniowa (NPWT). Niestety w niektórych przypadkach terapia ta jest niewystarczająca i wymaga uzupełnienia o inne metody.
Cel: Ocena zastosowania tlenoterapii hiperbarycznej (HBO2) w leczeniu DSWI u pacjentów po operacjach kardiochirurgicznych.
Materiał i metody: Retrospektywna analiza została przeprowadzona u 10 pacjentów z rozpoznanym DSWI operowanych w latach 2010–2012. Po 3 miesiącach nieefektywnego leczenia DSWI z wykorzystaniem antybiotykoterapii celowanej, chirurgicznego opracowania rany oraz NPWT pacjentów zakwalifikowano do leczenia HBO2 w modelu 20 sesji, każda po 92 minuty.
Wyniki: Po 4 tygodniach HBO2 u 7 pacjentów nastąpiło całkowite zagojenie rany mostka. Jeden pacjent został skierowany na kolejny cykl zabiegów i także u niego nastąpiło zagojenie się rany. U dwóch pacjentów, po 5 i 19 sesjach, HBO2 została przerwana z powodu złej kwalifikacji do procedury.
Wnioski: Tlenoterapia hiperbaryczna okazała się skuteczna u 80% pacjentów z rozpoznanym DSWI. Wydaje się skuteczną, tanią oraz bezpieczną metodą wspomagającą w leczeniu szczególnie trudnych, głębokich infekcji ran mostka. Ze względu na małą liczbę opisywanych przypadków otrzymane wyniki powinny stanowić wstęp do dalszych badań.
Keywords: deep sternal wound infection; hyperbaric oxygen therapy.
Figures
Similar articles
-
Effect of negative pressure wound therapy followed by tissue flaps for deep sternal wound infection after cardiovascular surgery: propensity score matching analysis.Interact Cardiovasc Thorac Surg. 2016 Sep;23(3):397-402. doi: 10.1093/icvts/ivw141. Epub 2016 May 18. Interact Cardiovasc Thorac Surg. 2016. PMID: 27199380
-
Hyperbaric oxygen therapy as an adjunctive treatment for sternal infection and osteomyelitis after sternotomy and cardiothoracic surgery.J Cardiothorac Surg. 2011 Oct 17;6:141. doi: 10.1186/1749-8090-6-141. J Cardiothorac Surg. 2011. PMID: 22004802 Free PMC article.
-
Hyperbaric oxygen for refractory osteomyelitis.Undersea Hyperb Med. 2021 Third Quarter;48(3):297-321. Undersea Hyperb Med. 2021. PMID: 34390634 Review.
-
Role of Negative Pressure Wound Care and Hyperbaric Oxygen Therapy for Sternal Wound Infections After Pediatric Cardiac Surgery.World J Pediatr Congenit Heart Surg. 2018 Jul;9(4):440-445. doi: 10.1177/2150135118772494. World J Pediatr Congenit Heart Surg. 2018. PMID: 29945514
-
Current perspectives on diagnosis and management of sternal wound infections.Infect Drug Resist. 2018 Jul 16;11:961-968. doi: 10.2147/IDR.S130172. eCollection 2018. Infect Drug Resist. 2018. PMID: 30038509 Free PMC article. Review.
Cited by
-
Review on risk factors, classification, and treatment of sternal wound infection.J Cardiothorac Surg. 2023 May 19;18(1):184. doi: 10.1186/s13019-023-02228-y. J Cardiothorac Surg. 2023. PMID: 37208736 Free PMC article. Review.
-
The Role of Hyperbaric Oxygen Therapy in the Treatment of Surgical Site Infections: A Narrative Review.Medicina (Kaunas). 2023 Apr 14;59(4):762. doi: 10.3390/medicina59040762. Medicina (Kaunas). 2023. PMID: 37109720 Free PMC article. Review.
-
Comparison Between Mini-Sternotomy and Full Sternotomy for Aortic Valve Replacement: A 10-Year Retrospective Study.Cureus. 2022 Nov 17;14(11):e31627. doi: 10.7759/cureus.31627. eCollection 2022 Nov. Cureus. 2022. PMID: 36540429 Free PMC article.
-
Early experience with the Thopaz+ chest drainage system - is this a new era in the management of post-cardiotomy bleeding?Kardiochir Torakochirurgia Pol. 2021 Dec;18(4):236-238. doi: 10.5114/kitp.2021.112191. Epub 2022 Jan 9. Kardiochir Torakochirurgia Pol. 2021. PMID: 35079266 Free PMC article.
-
Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives.Front Cell Dev Biol. 2021 Sep 10;9:704903. doi: 10.3389/fcell.2021.704903. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34568321 Free PMC article. Review.
References
-
- Braxton JH, Marrin CA, McGrath PD, Ross CS, Morton JR, Norotsky M, Charlesworth DC, Lahey SJ, Clough RA, O'Connor GT, Northern New England Cardiovascular Disease Study Group Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg. 2000;70:2004–2007. - PubMed
-
- Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation. 1995;92:2245–2251. - PubMed
-
- Kappstein I, Schulgen G, Fraedrich G, Schlosser V, Schumacher M, Daschner FD. Added hospital stay due to wound infections following cardiac surgery. Thorac Cardiovasc Surg. 1992;40:148–151. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources